(19)
(11) EP 2 261 317 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
23.04.2014 Bulletin 2014/17

(45) Mention of the grant of the patent:
01.05.2013 Bulletin 2013/18

(21) Application number: 09721080.1

(22) Date of filing: 13.03.2009
(51) International Patent Classification (IPC): 
C07K 7/64(2006.01)
A61K 36/06(2006.01)
A61P 17/00(2006.01)
C12R 1/645(2006.01)
 C12N 1/14(2006.01)
A61K 38/00(2006.01)
C12P 21/02(2006.01)
(86) International application number:
PCT/JP2009/054875
(87) International publication number:
WO 2009/113660 (17.09.2009 Gazette 2009/38)

(54)

MICROORGANISM PRODUCING CYCLIC COMPOUND

CYCLISCHE VERBINDUNG PRODUZIERENDER MIKROORGANISMUS

MICROORGANISME PRODUISANT UN COMPOSÉ CYCLIQUE

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 14.03.2008 JP 2008065201

(43) Date of publication of application:
15.12.2010 Bulletin 2010/50

(73) Proprietors:
  • Astellas Pharma Inc.
    Tokyo 103-8411 (JP)
  • Sirim Berhad
    Selangor Darul Ehsan 40911 (MY)
  • TropBio Research Sdn. Bhd.
    50100 Kuala Lumpur (MY)

(72) Inventors:
  • NAKAMURA, Ikuko
    Tokyo 103-8411 (JP)
  • YOSHIKAWA, Koji
    Tokyo 103-8411 (JP)
  • MASAKI, Teruhisa
    Tokyo 103-8411 (JP)
  • KANASAKI, Ryuichi
    Tokyo 103-8411 (JP)
  • SHAHAB, Neelam
    Selangor Darul Ehsan (MY)

(74) Representative: HOFFMANN EITLE 
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München
81925 München (DE)


(56) References cited: : 
EP-A1- 2 261 238
JP-A- 2007 269 954
 JP-A- 10 245 385
   
  • SHARMAN, G.J. ET AL.: 'Structural elucidation of XR586, a peptaibol-like antibiotic from Acremonium persicinum.' BIOCHEM J vol. 320, no. 3, 1996, pages 723 - 728, XP002149656
  • MORI, H. ET AL.: 'FR235222, a Fungal Metabolite, is a Novel Immunosuppressant that Inhibits Mammalian Histone Deacetylase. III. Structure Determination.' J ANTIBIOT vol. 56, no. 2, 2003, pages 181 - 185, XP008141490
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).